相关实验视频

Updated: Jan 12, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

用F-Flotufolastat进行前列腺癌成像18

David Gilmore¹, Daniel Tempesta²

¹Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts; and david.gilmore@mcphs.edu.

Journal of nuclear medicine technology

|November 4, 2025

概括

F-flotufolastat (Posluma) 通过向前列腺特异性膜抗原 (PSMA) 阳性病变,改善了转移前列腺癌的检测. 它有利的药理动力学增强可视化,有助于准确的分期和治疗计划.

科学领域:

核医学就是核医学.
在瘤学瘤学.
放射性药物开发放射性药物开发

背景情况:

前列腺癌转移的检测对于患者的生存率至关重要.
核医学和PSMA向的药物已经在前列腺癌成像方面取得了先进的进展.
由于膀活动等因素,在可视化盆腔病变方面仍然存在挑战.

研究的目的:

评估F-flotufolastat (Posluma) 在检测PSMA阳性前列腺癌病变中的作用.
在临床试验中突出F-flotufolastat的诊断准确性和安全性.
讨论F-flotufolastat在前列腺癌管理中的后勤和临床优势.

主要方法:

使用了F-flotufolastat,一种针对PSMA的新型PET放射性药物.
进行的临床试验 (例如,LIGHTHOUSE,SPOTLIGHT) 以评估诊断性能.
分析了药动力学特性,包括尿液分泌和膀活动.

主要成果:

F-flotufolastat在识别PSMA阳性病变方面表现出高的特异性和诊断准确性.
良好的药理动力学,包括尿液排泄率低,改善了病变的检测能力,特别是在骨盆区域.
临床试验证实了各种患者群体的良好的安全性.

结论:

F-flotufolastat (Posluma) 是核医学在前列腺癌成像方面的重大进展.
它精确可视化转移部位的能力为治疗决策提供了宝贵的见解.
该剂的特性为医疗机构提供了后勤效益,并为患者扫描提供了灵活性.

关键词:

18F-flotufolafolastat 的使用情况在PSMA上,PSMA可以在PSMA上进行交易.临床试验是指临床试验中的临床试验.发生转移的转移.前列腺癌是前列腺癌.前列腺特异性膜抗原前列腺特异性膜抗原

更多相关视频

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography

18F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor SiFA for Positron Emission Tomography

Published on: January 11, 2020

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies V: Intravenous Urography and Retrograde Pyelography

Imaging Studies V: Intravenous Urography and Retrograde Pyelography

IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...